Nac Al (Acetylcysteine)

Acetylcysteine, the active ingredient in Nac Al, is a mucolytic presented as an oral formulation for oral use. It helps to thin respiratory secretions and is used in chronic bronchitis, chronic obstructive pulmonary disease and acute respiratory tract infections. GNH USA supplies Nac Al as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Acetylcysteine acts as a mucolytic agent to improve clearance of airway secretions in several respiratory conditions.

Chronic bronchitis: reduces mucus viscosity and eases expectoration. Chronic obstructive pulmonary disease (COPD): assists in airway clearance and may improve breathing comfort. Acute respiratory tract infections: helps to loosen secretions and supports symptomatic relief.

Acetylcysteine may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nausea - Vomiting - Diarrhea - Abdominal discomfort - Rash or mild skin irritation - Headache

Serious or Rare Side Effects: - Anaphylactic reaction or severe hypersensitivity - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Bronchospasm, especially in asthmatic patients - Hepatic dysfunction or elevated liver enzymes - Neutropenia or other blood dyscrasias

Before using acetylcysteine, consider the following safety measures.

Assess renal function: adjust use in patients with severe renal impairment. Monitor hepatic function: watch for signs of liver enzyme elevation. Use with caution in asthma: bronchospasm may occur. Avoid in known hypersensitivity: discontinue if allergic reactions develop. Adjust dose in elderly: consider lower doses due to altered pharmacokinetics. Store at ambient temperature: keep in the original pack, protect from moisture.

Acetylcysteine can affect the activity of several concomitant medicines.

Major Interactions (Avoid): - Nitroglycerin: may potentiate hypotensive effects. - Activated charcoal: reduces acetylcysteine absorption. - Anticoagulants (e.g., warfarin): increased risk of bleeding.

Moderate Interactions (Monitor Closely): - Penicillins: possible reduction in antibacterial efficacy. - Carbamazepine: enzyme induction may lower acetylcysteine levels. - Oral contraceptives: may diminish hormonal effectiveness.